These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 9769337)

  • 21. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
    Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
    Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.
    Lindner D; Li J; Savvatis K; Klingel K; Blankenberg S; Tschöpe C; Westermann D
    Mediators Inflamm; 2014; 2014():519528. PubMed ID: 25374444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enterovirus-Cardiomyocyte Interactions: Impact of Terminally Deleted Genomic RNAs on Viral and Host Functions.
    Bouin A; Vu MN; Al-Hakeem A; Tran GP; Nguyen JHC; Semler BL
    J Virol; 2023 Jan; 97(1):e0142622. PubMed ID: 36475766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.
    Chen P; Xie Y; Shen E; Li GG; Yu Y; Zhang CB; Yang Y; Zou Y; Ge J; Chen R; Chen H
    Eur J Pharmacol; 2011 May; 658(2-3):168-74. PubMed ID: 21371462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain.
    Zhang H; Morgan-Capner P; Latif N; Pandolfino YA; Fan W; Dunn MJ; Archard LC
    Am J Pathol; 1997 Jun; 150(6):2197-207. PubMed ID: 9176409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
    Huber SA; Feldman AM; Sartini D
    Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.
    Abston ED; Coronado MJ; Bucek A; Onyimba JA; Brandt JE; Frisancho JA; Kim E; Bedja D; Sung YK; Radtke AJ; Gabrielson KL; Mitzner W; Fairweather D
    Am J Physiol Regul Integr Comp Physiol; 2013 Feb; 304(4):R267-77. PubMed ID: 23255589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis.
    Kaese S; Larbig R; Rohrbeck M; Frommeyer G; Dechering D; Olligs J; Schönhofer-Merl S; Wessely R; Klingel K; Seebohm G; Eckardt L
    PLoS One; 2017; 12(6):e0180029. PubMed ID: 28644868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major Persistent 5' Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues.
    Bouin A; Nguyen Y; Wehbe M; Renois F; Fornes P; Bani-Sadr F; Metz D; Andreoletti L
    Emerg Infect Dis; 2016 Aug; 22(8):1488-90. PubMed ID: 27434549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of viral infection in the myocardium of American and Japanese patients with idiopathic dilated cardiomyopathy.
    Fujioka S; Kitaura Y; Deguchi H; Shimizu A; Isomura T; Suma H; Sabbah HN
    Am J Cardiol; 2004 Sep; 94(5):602-5. PubMed ID: 15342290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
    Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
    J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
    Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy.
    Chapman NM; Kim KS
    Curr Top Microbiol Immunol; 2008; 323():275-92. PubMed ID: 18357775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in mice.
    Yanagawa B; Spiller OB; Choy J; Luo H; Cheung P; Zhang HM; Goodfellow IG; Evans DJ; Suarez A; Yang D; McManus BM
    Lab Invest; 2003 Jan; 83(1):75-85. PubMed ID: 12533688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
    Huber SA
    Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CVB infection and mechanisms of viral cardiomyopathy.
    Knowlton KU
    Curr Top Microbiol Immunol; 2008; 323():315-35. PubMed ID: 18357777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.
    Lee GH; Badorff C; Knowlton KU
    Circ Res; 2000 Sep; 87(6):489-95. PubMed ID: 10988241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of enteroviral genome and its significance in cardiomyopathy.
    Katsuragi M; Yutani C; Mukai T; Arai Y; Imakita M; Ishibashi-Ueda H; Hao H; Nagata S; Miyatake K
    Cardiology; 1993; 83(1-2):4-13. PubMed ID: 8261486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice.
    Yan X; Price RL; Nakayama M; Ito K; Schuldt AJ; Manning WJ; Sanbe A; Borg TK; Robbins J; Lorell BH
    Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2179-87. PubMed ID: 12869376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.